Document Detail


Clinical utility of myocardial fatty acid imaging in patients with end-stage renal disease.
MedLine Citation:
PMID:  18984459     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The prevalence of coronary artery disease (CAD) appears to be much higher in patients with end-stage renal disease (ESRD) undergoing dialysis than in a non-ESRD population. Cardiac death due to myocardial ischemia significantly contributes to the high mortality rate of ESRD patients. However, the method for screening for CAD in ESRD patients has not been established, because the frequency of silent myocardial ischemia is high and examinations requiring stress are often difficult to perform among this population. Myocardial fatty acid imaging may be a new modality to detect myocardial ischemia and identify the group at high risk for cardiac death among ESRD patients without adding any stress.
Authors:
Masato Nishimura; Toshihiko Ono
Related Documents :
12851609 - Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate.
12056739 - Prevalence and predictors of significant coronary artery disease in turkish patients wh...
7586339 - Compensatory vascular changes of remote coronary segments in response to lesion progres...
1462919 - Radiation-induced coronary artery disease.
20403579 - Serum levels of apelin and ghrelin in patients with acute coronary syndromes and establ...
3195479 - Doppler and two-dimensional echocardiographic assessment of left ventricular function b...
18949099 - Surgical implications of coronary arterial anatomy in adults with congenital cardiac di...
14578619 - Echocardiographic assessment of right ventricular obstruction in hypertrophic cardiomyo...
7717789 - On-site catheterization laboratory and prognosis after acute myocardial infarction. isr...
Publication Detail:
Type:  Journal Article     Date:  2008-09-16
Journal Detail:
Title:  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology     Volume:  15     ISSN:  1532-6551     ISO Abbreviation:  J Nucl Cardiol     Publication Date:    2008 Nov-Dec
Date Detail:
Created Date:  2008-11-05     Completed Date:  2009-04-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9423534     Medline TA:  J Nucl Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  830-7     Citation Subset:  IM    
Affiliation:
Cardiovascular Division, Toujinkai Hospital, Fushimi-ku, Kyoto, Japan. mnishimura@tea.ocn.ne.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Coronary Angiography / methods
Fatty Acids / metabolism*
Heart / radionuclide imaging
Humans
Kidney Failure, Chronic / diagnosis*,  radionuclide imaging
Myocardial Ischemia / pathology
Myocardium / pathology*
Oxygen / chemistry,  metabolism
Renal Dialysis
Reproducibility of Results
Sensitivity and Specificity
Tomography, Emission-Computed, Single-Photon / methods*
Chemical
Reg. No./Substance:
0/Fatty Acids; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reversible impairment of coronary flow reserve in takotsubo cardiomyopathy: a myocardial PET study.
Next Document:  The global impact of hepatic fibrosis and end-stage liver disease.